Blood conservation strategies in major orthopaedic surgery: Efficacy, safety and European regulations

Vox Sanguinis

Volumn 96, Issue 1, 2009, Pages 1-13

  Munoz M ^a,e   Garcia Erce J A ^b   Villar, I ^b   Thomas, D ^c,d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c MORRISTON HOSPITAL   (United Kingdom)

^d Welsh Blood Service   (United Kingdom)

^e UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

Allogeneic blood transfusion; Antifibrinolytic drugs; Autologous blood donation; Erythropoietin; European Directives; Fibrin sealant; Iron; Perioperative red blood cell salvage; Transfusion protocol

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRIN GLUE; IRON; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLEEDING; BLOOD CONSERVATION; BLOOD DONOR; BLOOD TRANSFUSION; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG FATALITY; DRUG SAFETY; ERYTHROCYTE; ERYTHROPOIESIS; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HEMODILUTION; HEMOSTASIS; HIP FRACTURE; HUMAN; INTRACARDIAC THROMBOSIS; IRON DEFICIENCY; KIDNEY DISEASE; LIMB SWELLING; MEDICAL PRACTICE; MEDICAL RESEARCH; MORBIDITY; OCCLUSIVE CEREBROVASCULAR DISEASE; ORTHOPEDIC SURGERY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; THROMBOSIS; TOTAL KNEE REPLACEMENT; VEIN THROMBOSIS; WOUND COMPLICATION; WOUND DRAINAGE; WOUND HEMORRHAGE; WOUND INFECTION;

ADULT; AGED; ANEMIA; BLOOD BANKS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; BLOODLESS MEDICAL AND SURGICAL PROCEDURES; EUROPEAN UNION; EVIDENCE-BASED MEDICINE; HEMATINICS; HEMODILUTION; HUMANS; IRON; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OPERATIVE BLOOD SALVAGE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOPHILIA;

EID: 57449115155     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01108.x     Document Type: Review

References (82)

1. Stanworth SJ, Cockburn HA, Boralessa H, Contreras M : Which groups of patients are transfused? A study of red cell usage in London and Southeast England. Vox Sang 2002 83 : 352 357
2. Wallis JP, Wells AW, Chapman CE on behalf of the Northern Regional Transfusion Committee : Changing indications for red cell transfusion from 2000 to 2004 in the North of England. Transfus Med 2000 16 : 411 417
3. The Serious Hazards of Transfusion Steering Group : Annual Report 2006 available at http://www.shotuk.org/SHOT_report_2006.pdf
4. Klein HG, Spahn DR, Carson JL : Red blood cell transfusion in clinical practice. Lancet 2007 370 : 415 426
5. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G : Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999 39 : 694 700
6. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB : An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999 81 : 2 10
7. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL OSTHEO Investigation : Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003 43 : 459 469
8. Leal-Noval R, Muñoz M, Páramo JA, García-Erce JA for the Spanish Expert Panel on Alternatives to Allogeneic Blood Transfusion : Spanish consensus statement on alternatives to allogeneic blood transfusions: the 'Seville document'. Transfus Alternat Transfus Med 2006 8 : 178 202
9. Gombotz H, Rehak PH, Shander A, Hofmann A : Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007 47 : 1468 1480
10. Scottish Intercollegiate Guidelines Network : Perioperative Blood Transfusion for Elective Surgery: A National Clinical Guideline, 2001 available at http://www.sign.ac.uk/guidelines/fulltext/54/index.html http://www.sign.ac.uk
11. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, Duguid J, Knowles SM, Poole G, Williamson LM British Committee for Standards in Haematology, Blood transfusion Task Force: Guidelines for the clinical use of red cell transfusion. Br J Haematol 2001 113 : 24 32
12. Ortiz P, Mingo A, Lozano M, Vesga MA, Grifols JR, Castrillo A, Algora M, Romón I, Cárdenas JM : Guide for transfusion of blood components. Med Clin (Barc) 2005 125 : 389 396
13. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H : A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998 38 : 522 529
14. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, Brett S, Goldhill DR, Soni N : Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006 90 : 105 112
15. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, O'Hara DA, Noveck H, Strom BL : Perioperative blood transfusion and postoperative mortality. JAMA 1998 279 : 199 205 (Level II)
16. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, Radovancevic B, McAllister HA, Jr., Cooley DA : Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999 39 : 1070 1077 (Level II)
17. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E : A multicenter, randomized, controlled clinical trial of tranfusion requeriments in critical care. N Engl J Med 1999 340 : 409 417 (Level I)
18. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD : Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007 297 : 2481 2488
19. Saleh E, McClelland DBL, Hay A, Semple D, Walsh TS : Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 2007 99 : 801 808
20. Muñoz M, García-Erce JA, Cuenca J, Bisbe E : Pharmacological management of perioperative anaemia: our experience with intravenous iron in orthopaedic surgery. ISBT Science Series 2007 2 : 257 263
21. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C : Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002 84-A : 216 220
22. Aderinto J, Brenkel IJ : Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br 2004 86-B : 970 973
23. García-Erce JA, Solano VM, Cuenca J, Ortega P : La hemoglobina preoperatoria como único factor predictor de las necesidades transfusionales en la artroplastia de rodilla. Rev Esp Anestesiol Reanim 2002 49 : 254 260
24. García-Erce JA, Cuenca J, Solano VM : Factores predictivos de la necesidad de transfusión en la fractura subcapital de cadera en pacientes mayores de 65 años. Med Clin (Barc) 2003 120 : 161 166
25. Muñoz M, Breymann C, García-Erce JA, Gómez- Ramírez S, Comin J, Bisbe E : Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008 94 : 172 183
26. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P : Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008 100 : 599 604
27. Cuenca J, García-Erce JA, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M : Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Inter J Surg 2007 5 : 89 94 (Level IV)
28. Cuenca J, García-Erce JA, Muñoz M, Izuel M, Martínez AA, Herrera A : Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004 44 : 1447 1452 (Level IV)
29. Cuenca J, García-Erce JA, Martínez AA, Solano VM, Molina J, Muñoz M : Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 2005 125 : 342 347 Level IV
30. García-Erce JA, Cuenca J, Muñoz M, Izuel M, Martínez AA, Herrera A, Solano VM, Martínez F : Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005 88 : 235 243 (Level III)
31. Cuenca J, Garcia-Erce JA, Martinez F, Pérez-Serrano L, Herrera A, Muñoz M : Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006 46 : 1112 1129 (Level III)
32. Izuel M, Gómez-barrera M, Villar I, Rabaneque MJ, Cuenca J, García-Erce JA : Análisis del impacto presupuestario de la implantación de medidas de ahorro de sangre en cirugía de urgencia. Med Clin (Barc) 2007 128 : 7 11 (Level III)
33. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T : Treatment of anaemia after joint replacement. J Bone Joint Surg Br 2004 86-B : 31 33 (Level II)
34. Mundy GM, Birtwistle SJ, Power RA : The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. J Bone Joint Surg Br 2005 87-B : 213 217 (Level II)
35. Bernière J, Dehullu JP, Gall O, Murat I : Intravenous iron in the treatment of postoperative anaemia in surgery of the spine in infants and adolescents. Rev Chir Orthop 1998 84 : 319 322 (Level IV)
36. Muñoz M, Naveira E, Seara J, Palmer JH, Cuenca J, García-Erce JA : Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. Transfus Med 2006 16 : 137 142 (Level IV)
37. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM : Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anesth 2006 53 : 11 19 (Level II)
38. García-Erce JA, Cuenca J, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M : Perioperative intravenous iron preserves iron stores and may hasten the recovery from postoperative anaemia after knee replacement surgery. Transfus Med 2006 16 : 335 341
39. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J : Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006 21 : 378 382
40. Casalduero J, García-Erce JA, Muñoz M, Cuenca J, Izuel M, Giralt M : Short-term benefit of iron sucrose treatment in patients sustaining hip surgery: reduction of transfusion and infection rates. A meta-analysis. Transfus Altern Transfus Med 2008 10 : 43 44
41. García-Erce JA, Cuenca J, Muñoz M : Role of intravenous iron in elective and non-elective orthopedic surgery. Semin Hematol 2006 34 : S32 S35
42. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY : Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. Ann Intern Med 2000 133 : 845 854 (Level I)
43. Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, van Os J, Vosmaer A, van der Ark P : Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005 22 : 249 257 (Level I)
44. Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R : Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anesth 2005 52 : 363 368 (Level III)
45. Slappendel R, Weber EW, Hémon YJ, Mähler S, Dalén T, Rouwet EF, van Os JJ, Vosmaer A, van der Ark PD : Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-α treatment. Acta Orthop 2006 77 : 677 683 (Level II)
46. Rosencher N, Poisson D, Albi A, Aperce M, Barré J, Samama CM : Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anesth 2005 52 : 160 165 (Level II)
47. Habler O : Indications for perioperative blood transfusion in orthopedic surgery. Transfus Altern Transfus Med 2006 8 : 17 28
48. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S : Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006 105 : 1034 1046 (Level I)
49. Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, Salazar F, Cid J, Lozano L, Mazzara R, Macule F : Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 2008 95 : 39 44 (Level IV)
50. Johansson PI : Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials. Vox Sang 2008 95 : 1 7
51. Raobaikady R, Redman J, Ball JAS, Maloney G, Grounds RM : Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. Br J Anaesth 2005 94 : 586 591 (Level II)
52. Sachs B, Delacy D, Green J, Graham RS, Ramsay J, Kreisler N, Kruse P, Khutoryansky N, Hu SS : Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. Spine 2007 32 : 2285 2293 (Level II)
53. Radosevich M, Goubran HI, Burnouf T : Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997 7 : 133 143
54. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H : The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999 81-A : 1580 1588 (Level II)
55. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD : Use of fibrin sealant to reduce bloody drainage and haemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001 83-A : 1503 1505 (Level II)
56. Everts PAM, Devilee RJJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HAM, Knape JTA, van Zundert A : Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006 50 : 593 599 (Level III)
57. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE : Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomized controlled trial. J Bone Joint Surg Br 2007 89-B : 306 309 (Level II)
58. Lassen MR, Solgaard S, Kjersgaard AG, Olsen C, Lind B, Mittet K, Ganes HC : A pilot study of the effects of Vivostat patient-derived fibrin sealant in reducing blood loss in primary hip arthroplasty. Clin Appl Thromb Hemost 2006 12 : 352 357 (Level II)
59. Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T : Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg 2006 14 : 117 121 (Level II)
60. MacGillivray TE : Fibrin sealants and glues [Review]. J Card Surg 2003 18 : 480 485
61. Parker MJ, Roberts CP, Hay D : Closed suction drainage for hip and knee arthroplasty. A meta-analysis. J Bone Joint Surg Am 2004 86-A : 1146 1152 (Level I)
62. Walmsley PJ, Kelly MB, Hill RM, Brenkel I : A prospective, randomized, controlled trial of the use of drains in total hip arthroplasty. J Bone Joint Surg Br 2005 87-B : 1379 1401 (Level I)
63. Tjeenk RM, Vrancken Peeters MP, van den Ende E, Kastelein GW, Breslau PJ : Wound drainage versus non-drainage for proximal femoral fractures. A prospective randomised study. Injury 2005 36 : 100 104 (Level II)
64. Tsumara N, Yoshiya S, Chin T, Shiba R, Kohso K, Doita M : A prospective comparison of clamping the drain or post-operative salvage of blood in reducing blood loss after total knee arthroplasty. J Bone Joint Surg Br 2006 88-B : 49 53 (Level II)
65. Carless P, Moxey A, O'Connell D, Henry D : Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 2004 14 : 123 144 (Level I)
66. Bezwada HP, Nazarian DG, Henry DH, Booth RE : Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J Bone Joint Surg Am 2003 85A : 1795 1800 (Level II)
67. García-Erce JA, Solano VM, Sáez M, Muñoz M : Recombinant human erythropoietin facilitates autologous blood donation in children undergoing corrective spinal surgery. Transfusion 2004 44 : 1447 1452 (Level III)
68. García-Erce JA, Muñoz M, Bisbe E, Sáez M, Solano VM, Beltrán S, Ruiz A, Cuenca J, Vicente-Thomas J : Predeposit autologous donation in spinal surgery. A multicentre study. Eur Spine J 2004 13 (Suppl. 1 S34 S39 (Level III)
69. Boulton FE, James V British Committee for Standards in Haematology, Transfusion Task Force : Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion. Transfus Med 2007 17 : 354 365
70. Huet C, Salmi LR, Fergusson D, Koopman-van Gements AW, Rubens F, Laupacis A International Study of Peri-operative Transfusion (ISPOT) Investigators : A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. Anesth Analg 1999 89 : 861 869 (Level I)
71. Thomas D, Wareham K, Cohen D, Hutching H : Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001 86 : 669 673 (Level I)
72. Muñoz M, Ariza D, Garcerán MJ, Gómez A, Campos A : Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement. Arch Orthop Trauma Surg 2005 125 : 385 389 (Level IV)
73. Muñoz M, Kühlmorgen B, Ariza D, Haro E, Marroquí A, Ramírez G : Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures. Vox Sang 2007 92 : 136 141 (Level III)
74. Woolson ST, Wall WW : Autologous blood transfusion after total knee arthroplasty. A randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty 2003 18 : 243 249 (Level II)
75. Mauerhan DR, Nussman D, Mokris JG, Beaver WB : Effect of postoperative reinfusion systems on haemoglobin levels in primary total hip and total knee arthroplasties. A prospective randomized study. J Arthroplasty 1993 8 : 523 527 (Level II)
76. Glynn A, McCarthy T, McCarroll M, Murray P : A prospective audit of blood usage post primary total knee arthroplasty. Acta Orthop Belg 2006 72 : 24 28 (Level III)
77. Hansen E, Pawlik M : Reasons against the retransfusion of unwashed wound blood. Transfusion 2004 44 : 45S 53S
78. Shander A, Rijhwani TS : Acute normovolemic hemodilution. Transfusion 2004 44 : S26 S34
79. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E : Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004 44 : 632 644 (Level I)
80. Angela E, Robinson E : The European Union Blood Safety Directive and its implications for blood services. Vox Sang 2007 93 : 122 130
81. Sazama K : The ethics of blood management. Vox Sang 2007 92 : 95 102
82. British Committee for Standards in Haematology Blood Transfusion Task Force : Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. Br J Anaesth 1997 78 : 768 771